Mesenteric venous thrombosis (MVT) is a serious vascular disorder characterized by the formation of a thrombus in the mesenteric veins, which are responsible for the outflow of blood from the intestine. This condition can lead to intestinal ischemia, which in turn can cause necrosis and other serious complications. MVT can manifest itself acutely or chronically and is often associated with important factors such as the presence of pre-existing diseases, hypercoagulability, and other risks. This pathology requires timely medical evaluation and intensive intervention to prevent serious life-threatening conditions for the patient.
History of the disease and interesting historical facts
Mesenteric venous thrombosis was first described in the medical literature in the early 19th century, when a more in-depth analysis of vascular diseases associated with the intestines was carried out. At that time, diagnostics remained poor and therapeutic approaches were limited. Interestingly, the survival rate of patients with MVT has improved significantly with the development of medical technology and imaging techniques. The late 20th century saw the widespread use of angiography and, subsequently, computed tomography, which allowed physicians to more effectively diagnose and treat this condition.
Epidemiology
According to recent epidemiological studies, MVT is a relatively rare disease, but its incidence is increasing, especially among the elderly and patients with comorbidities. According to various sources, the incidence of mesenteric venous thrombosis ranges from 11% to 51% of all cases of acute abdomen. Misdiagnosis and late seeking of medical care can lead to a high mortality rate, reaching 30-50% of all cases.
Genetic predisposition to this disease
Certain types of genetic disorders and mutations may increase the risk of developing mesenteric venous thrombosis. In particular, the following factors predominate:
- Mutations in genes responsible for blood coagulation, such as factor V Leiden and mutations in proteins C and S.
- Genetic predisposition to thrombophilia, including antithrombin deficiencies.
These factors may predispose patients to hypercoagulability and, consequently, to the formation of thrombi in the mesenteric veins.
Risk factors for the development of this disease
There are many risk factors that contribute to the development of mesenteric venous thrombosis, including:
- Age over 60 years.
- Chronic diseases such as cancer, cardiovascular disease, and chronic lung disease.
- Obesity and sedentary lifestyle.
- Previous operations on abdominal organs.
- Routes of catheter insertion and other invasive procedures.
- Hormonal therapy and use of oral contraceptives.
Diagnosis of this disease
Diagnosis of mesenteric venous thrombosis includes several main stages:
- The main symptoms are acute abdominal pain, vomiting, diarrhea and possible fever.
- Laboratory tests include blood tests for coagulation and determination of inflammatory markers.
- Radiological examinations: ultrasound examination of abdominal organs and computed tomography with contrast.
- Other diagnostic tests, such as angiography.
- Differential diagnosis includes conditions such as intestinal perforation or acute appendicitis.
Treatment
Treatment of mesenteric venous thrombosis requires a comprehensive approach:
- General treatment includes supportive care and interventions to improve blood flow.
- Pharmacological treatment: anticoagulants such as heparin or warfarin.
- Surgery may be necessary to remove the thrombus or resect necrotic areas of the intestine.
- Other treatments, including endovascular procedures, may be used depending on the clinical situation.
List of drugs used to treat this disease
The main groups of drugs used to treat mesenteric venous thrombosis are:
- Anticoagulants: heparin, enoxaparin, warfarin.
- Thrombolytics: streptokinase, alteplase.
- Supportive care: fluids and electrolytes.
- Analgesics: to relieve pain.
Disease monitoring
Monitoring of the patient's condition with mesenteric venous thrombosis includes:
- Regular check-ups to assess bowel health and overall health.
- Laboratory tests to monitor the hemostasis system.
- The prognosis depends on the time of assistance, fear factors such as the presence of concomitant diseases.
- Complications may include intestinal ischemia, intestinal perforation, and sepsis.
Age-related features of the disease
Mesenteric venous thrombosis may present differently in different age groups:
- Older people are at high risk due to the presence of comorbidities and genetic predisposition.
- Young patients often have thrombophilia or factors associated with thrombus formation.
- Children are able to tolerate the disease, but late diagnosis can lead to serious consequences.
Questions and Answers
- What are the main symptoms of mesenteric venous thrombosis? The main symptoms include severe abdominal pain, vomiting, diarrhea and possible fever.
- How is mesenteric venous thrombosis diagnosed? Diagnostics includes blood tests, ultrasound and CT scan with contrast.
- What is the treatment for mesenteric venous thrombosis? Treatment may include anticoagulants, thrombolytics, and surgery.
- What are the risk factors for this disease? Risk factors include age, obesity, chronic diseases and previous surgeries.
- What is the prognosis for patients with mesenteric venous thrombosis? The prognosis depends on the time of seeking medical help and the presence of concomitant diseases.
